Novartis Investigative Site

Mount Pearl, Newfoundland and Labrador A1N 1W7

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Systolic Hypertension

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension — Completed